AAPM/RSNA physics tutorial for residents: MR artifacts, safety, and quality control

Radiographics

Volumn 26, Issue 1, 2006, Pages 275-297

  Zhuo, Jiachen ^a   Gullapalli, Rao P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFACT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY CONTROL; SAFETY; STANDARD;

ARTIFACTS; HUMANS; MAGNETIC RESONANCE IMAGING; QUALITY CONTROL; SAFETY;

EID: 32544439888     PISSN: 15271323     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.261055134     Document Type: Article

References (56)

1. Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. (1973.) Clin Orthop Relat Res 1989;244:3-6.
2. Lewin JS, Laub G, Hausmann R. Three-dimensional time-of-flight MR angiography: applications in the abdomen and thorax. Radiology 1991;179: 261-264.
3. Petitjean C, Rougon N, Cluzel P. Assessment of myocardial function: a review of quantification methods and results using tagged MRI. J Cardiovasc Magn Reson 2005;7:501-516.
4. McKnight TR. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 2004;31:605-617.
5. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7:91-101.
6. Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A 1992;89: 5951-5955.
7. Hayes CE, Hattes N, Roemer PB. Volume imaging with MR phased arrays. Magn Reson Med 1991;18:309-319.
8. Sodickson DK, McKenzie CA, Ohliger MA, Yeh EN, Price MD. Recent advances in image reconstruction, coil sensitivity calibration, and coil array design for SMASH and generalized parallel MRI. MAGMA 2002;13:158-163.
9. Mansfield P. Multi-planar image formation using NMR spin echoes. J Phys C 1977;10:L55-L58.
10. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast method for clinical MR. Magn Reson Med 1986;3:823-833.
11. Mezrich R. A perspective on k-space. Radiology 1995;195:297-315.
12. Twieg DB. The k-trajectory formulation of the NMR imaging process with applications in analysis and synthesis of imaging methods. Med Phys 1983;10:610-621.
13. Hennig J. Generalized MR interferography. Magn Reson Med 1990;16:390-402.
14. Axel L, Montillo A, Kim D. Tagged magnetic resonance imaging of the heart: a survey. Med Image Anal 2005;9:376-393.
15. Wood ML, Henkelman RM. Magnetic resonance artifacts from periodic motion. Med Phys 1985; 12:143-151.
16. Bailes DR, Gilderdale DJ, Bydder GM, Collins AG, Firmin DN. Respiratory ordered phase encoding (ROPE): a method for reducing respiratory motion artifacts in MR imaging. J Comput Assist Tomogr 1985;9:835-838.
17. Ehman RL, Felmlee JP. Adaptive technique for high-definition MR imaging of moving structures. Radiology 1989;173:255-263.
18. Butts K, Riederer SJ, Ehman RL, Thompson RM, Jack CR. Interleaved echo planar imaging on a standard MRI system. Magn Reson Med 1994; 31:67-72.
19. McGee KP, Felmlee JP, Manduca A, Riederer SJ, Ehman RL. Rapid autocorrection using prescan navigator echoes. Magn Reson Med 2000;43:583-588.
20. Pattany PM, Phillips JJ, Chiu LC, et al. Motion artifact suppression technique (MAST) for MR imaging. J Comput Assist Tomogr 1987;11:369-377.
21. Kolind SH, MacKay AL, Munk PL, Xiang QS. Quantitative evaluation of metal artifact reduction techniques. J Magn Reson Imaging 2004;20:487-495.
22. Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. RadioGraphics 1999;19:357-371.
23. Farzaneh F, Riederer SJ, Pelc NJ. Analysis of T2 limitations and off-resonance effects on spatial resolution and artifacts in echo-planar imaging. Magn Reson Med 1990;14:123-139.
24. Bydder GM, Young IR. MR imaging: clinical use of the inversion recovery sequence. J Comput Assist Tomogr 1985;9:659-675.
25. Nakatsu M, Hatabu H, Itoh H, et al. Comparison of short inversion time inversion recovery (STIR) and fat-saturated (chemsat) technique for background fat intensity suppression in cervical and thoracic MR imaging. J Magn Reson Imaging 2000;11:56-60.
26. Mitchell DG, Kim I, Chang TS, et al. Fatty liver: chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms and humans. Invest Radiol 1991; 26:1041-1052.
27. Bracewell R. The Fourier transform and its applications. New York, NY: McGraw-Hill, 1978.
28. Doran SJ, Charles-Edwards L, Reinsberg SA, Leach MO. A complete distortion correction for MR images. I. Gradient warp correction. Phys Med Biol 2005;50:1343-1361.
29. Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38:591-603.
30. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
31. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002; 47:1202-1210.
32. Goldfarb JW. The SENSE ghost: field-of-view restrictions for SENSE imaging. J Magn Reson Imaging 2004;20:1046-1051.
33. Larkman DJ, Atkinson D, Hajnal JV. Artifact reduction using parallel imaging methods. Top Magn Reson Imaging 2004;15:267-275.
34. Bammer R, Schoenberg SO. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 2004; 15:129-158.
35. Food and Drug Administration (FDA), Center for Devices and Radiological Health, Computed Imaging Devices Branch, Office of Device Evaluation. Guidance for the submission of premarket notifications for magnetic resonance diagnostic devices. Web site of the FDA. http://www.fda.gov /cdrh/ode/mri340.pdf. Published November 14, 1998. Accessed November 17, 2005.
36. Marsh JL, Armstrong TJ, Jacobson AP, Smith RG. Health effect of occupational exposure to steady magnetic fields. Am Ind Hyg Assoc J 1982; 43:387-394.
37. Tenford TS, Budinger RF. Biological effects and physical safety aspects of NMR imaging and in vivo spectroscopy. In: Thomas SR, Dixon RL, eds. NMR in medicine: the instrumentation and clinical applications. Medical Physics Monograph no. 14. College Park, Md: American Institute of Physics, 1986; 493-548.
38. Sahl J, Mezei G, Kavet R, et al. Occupational magnetic field exposure and cardiovascular mortality in a cohort of electric utility workers. Am J Epidemiol 2002;156:913-918.
39. Schenck JF. Safety of strong, static magnetic fields. J Magn Reson Imaging 2000;12:2-19.
40. Formica D, Silvestri S. Biological effects of exposure to magnetic resonance imaging: an overview. Biomed Eng Online 2004;3:11.
41. Food and Drug Administration (FDA). Public health notification: MRI-caused injuries in patients with implanted neurological stimulators. Web site of the FDA. http://www.fda.gov/cdrh /safety/neurostim.html. Published May 10, 2005. Accessed November 17, 2005.
42. Shellock FG. Pocket guide to MR procedures and metallic objects: update 2001. Baltimore, Md: Lippincott Williams & Wilkins, 2001.
43. Ham CL, Engels JM, van de Wiel GT, Machielsen A. Peripheral nerve stimulation during MRI: effects of high gradient amplitude and switching rates. J Magn Reson Imaging 1997;7:933-937.
44. Theriault G, Goldberg M, Miller AB, et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol 1994;139:550-572. [Published correction appears in Am J Epidemiol 1994; 139:1053.]
45. Villeneuve PJ, Agnew DA, Johnson KC, Mao Y. Canadian Cancer Registries Epidemiology Research Group. Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control study. Int J Epidemiol 2002;31:210-217.
46. Bracken TD, Patterson RM. Variability and consistency of electric and magnetic field occupational exposure measurements. J Expo Anal Environ Epidemiol 1996;6:355-374. [Published corrections appear in J Expo Anal Environ Epidemiol 1996;6(4):527, J Expo Anal Environ Epidemiol 1997;7:553.
47. Schaefer DJ, Bourland JD, Nyenhuis JA. Review of patient safety in time-varying gradient fields. J Magn Reson Imaging 2000;12:20-29.
48. International Electrotechnical Commission. Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. In: Diagnostic imaging equipment. Publication no. 60601-2-33. Medical electrical equipment. Geneva, Switzerland: International Electrotechnical Commission, 1995.
49. McJury M, Shellock FG. Auditory noise associated with MR procedures: a review. J Magn Reson Imaging 2000;12:37-45.
50. Roberts NJ Jr, Michaelson SM, Lu ST. The biological effects of radiofrequency radiation: a critical review and recommendations. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:379-420.
51. Shellock FG. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging 2000;12:30-36.
52. Lerski RA, McRobbie DW, Straughan K, Walker PM, de Certaines JD, Bernard AM. Multi-center trial with protocols and prototype test objects for the assessment of MRI equipment. EEC Concerted Research Project. Magn Reson Imaging 1988;6:201-214.
53. Och JG, Clarke GD, Sobol WT, Rosen CW, Mun SK. Acceptance testing of magnetic resonance imaging systems: report of AAPM Nuclear Magnetic Resonance Task Group No. 6. Med Phys 1992; 19:217-229.
54. McRobbie DW, Quest RA. Effectiveness and relevance of MR acceptance testing: results of an 8 year audit. Br J Radiol 2002;75:523-531.
55. American College of Radiology (ACR). MRI Accreditation Program requirements. Web site of the ACR. http://www.acr.org/s_acr/sec.asp?CID= 1744&DID=12150&DOC=FILE.PDF. Published September 21, 2005. Accessed November 17, 2005.
56. American College of Radiology (ACR). Phantom test guidance for the ACR MRI Accreditation Program. Reston, Va: ACR, 1998.